Company
A new era for human health
Welcome to our Canadian website. GSK is a global biopharma company with the ambition and purpose to unite science, technology and talent to get ahead of disease together.
Ahead together
Our purpose
As a focused biopharma company, we discover, develop and deliver medicines and vaccines to create value for patients and shareholders. We aim to positively impact the health of 2.5 billion people by the end of the decade.Our R&D focus is on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases.
$3 mil +
contributed over the last 20 years to support the hospice palliative care movement in Canada
GSK Global links
Visit our Global site for additional features
Press releases
- GSK enters agreement to acquire 35Pharma Inc.
- Survey finds majority of older Canadians with chronic illnesses unaware of increased shingles risk
- Quebec first province to publicly reimburse Jemperli (dostarlimab for injection) plus chemotherapy via RAMQ for the treatment of all adult patients with primary advanced or first recurrent endometrial cancer
